24x7 Online KPK Pharmacy’s Post

#MorningIndia | Your daily News tracker! ☕ ✅ Zydus receives US approval for generic schizophrenia medication ✅ Partha Sengupta approved as MD & CEO of Bandhan Bank by RBI ✅ 314 housing projects in Maharashtra are facing insolvency #Zydus #Pharma #Bandhan #RERA #ShareMarket #ShareMarketIndia #IndianShareMarket #IndianStockMarket #FinanceNews #Finance101 #Finance #IndianFinance #MotilalOswal

🔉 Expanding Jan Aushadhi Kendras to 25,000 by 2027 💊 ◾ The Department of Pharmaceuticals (DoP) sets an ambitious target of 25,000 Jan Aushadhi Kendras (JAKs) by 2027 under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). ◾ As of June 2024, 12,616 JAKs have been established, with Uttar Pradesh (2,210) leading, followed by Kerala (1,228), Karnataka (1,225), and Tamil Nadu (1,107). ◾ The PMBJP has enabled Rs. 30,000 crores in savings for citizens, with medicine prices reduced by 50-90% compared to branded alternatives. ◾ Despite significant progress, the task remains challenging with 743 out of 764 districts covered but many states lagging in JAK openings. ◾ The PMBJP scheme, revamped in 2016 under the current government, has not only provided affordable medicines but also created self-employment opportunities for entrepreneurs. ◾ The product basket includes around 2000 medicines and 300 surgical instruments, with new products like protein powders, nutraceuticals, and medical devices launched under the scheme. ◾ The challenge remains as the government must open 12,000 more outlets in the next three years to meet the target. #PharmaIndustry #JanAushadhi #AffordableHealthcare #GovernmentInitiatives #SelfEmployment #PMBJP #GenericMedicines #HealthcareTransformation #PublicHealth #IndiaGrowth

#Approx #MedicalDeviceMarket Growth by Region in India - Maharashtra: $1.5B - Tamil Nadu: $1.2B - Karnataka: $1B - Gujarat: $900M "India’s medical device market is expanding rapidly, with Maharashtra leading the charge at $1.5B. As healthcare needs increase, the demand for advanced medical technologies is driving this growth. How can Indian companies innovate further to serve both domestic and international markets?"

Suraksha Diagnostic Limited is coming up with its IPO. Established in 2005, this company is a leader in pathology, radiology, and medical consultancy services. With 44 diagnostic centres, 120 polyclinics, and 750+ doctors, the company serves West Bengal, Bihar, Assam, and Meghalaya, leveraging advanced tech systems like LIMS, RIS, PACS, and ERP. IPO Details: IPO Date: 29th Nov – 3rd Dec 2024 Price Band: ₹420 – ₹441 per share Lot Size: 34 shares Issue Size: ₹846.25 Cr Read more: https://lnkd.in/dYh4FaZG Source: Company's RHP Disclaimer: https://lnkd.in/dJuz2Sjb #SurakshaDiagnosticIPO #IPOAlert #DiagnosticsSector #StockMarketUpdates #HealthcareIndustry #IPO2024 #StockMarketIndia #InvestmentOpportunity #Healthcare #DiagnosticsMarket #IndianHealthcare #IssueDetails #Strengths #Strategies #CompanyOverview

💉 APPLICATION OF DISPOSABLE IV SETS💉 • Minimizing the risk of infusion reactions, alleviating pain during the process, and safeguarding access sites. • These sets are essential for accurately administering both large and controlled doses of medication. • They connect the medication to the needle. inserted into the patient, ensuring a smooth and efficient delivery. • Disposable IV sets are indispensable in administering chemotherapy and other treatments that require extended infusion times. 📍 1st Floor, Parag Plaza, Guraiya Rd, Near Devbhoomi Developers, Sanchara Colony, Chhindwara, Madhya Pradesh 480001 📞 +91 78793 93035 📧 sales@fortunegroupofcompanys.com #FortuneCarecroft #Healthcare #SafetyFirst #MedicalSupplies #HealthCareSolutions See less

⁉️When should I opt for a #ureteroscopy - Dr.MKD answers #Ureteroscopy #URS #SEMIRIGIDURS . . . . 🗿All you need to know about renal stone treatment! 📢 SERIES : KIDNEY STONES TREATMENT, SERIES - 2, REEL episode : #3 Follow for more scientific content ⬆️ FOLLOW ! 📞 7305140046 for consultation. AVAILABLE @ #Adyar #Besantnagar #Thiruvanmyur #ECR #OMR #PALLIKARNAI #VADAPALANI Watch the full 📹VIDEO ON - YOUTUBE 🎥LINK in BIO ✨

#WHO alerts on the tobacco industry's new approach: identical nicotine, fresh packaging. Disturbing data reveals their mission to captivate youth with enticing flavours, sleek designs, and targeted social media ads, all while keeping health risks intact. Why should you be worried? 85% of high school-aged smokers reach for a vape over regular cigarettes. Vaping delivers nicotine levels comparable to a pack of cigarettes per pod, disrupting adolescent brain development. It exposes users to harmful substances like diacetyl, heavy metals, and carcinogens, posing serious pulmonary health risks. Aerosolized liquids can irritate the throat. Teen vapers face heightened risks of anxiety, depression, ADHD, and impaired impulse control, affecting crucial brain functions for learning and memory. Despite exposure to anti-smoking campaigns, many in Gen Z overlook vaping's dangers. Let's bridge this awareness gap to safeguard against nicotine addiction. Know more https://lnkd.in/dUDHEyyY and visit to receive care from the best ENT specialist in Nashik! #HealthTalk #HealthNews #Healthcare #Nursing #PatientSafety #DIGIPHIN

🚀 Growth Milestone for Jan Aushadhi Kendras!🚀 In September, the Jan Aushadhi Kendras (JAKs) under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) achieved a remarkable 43% increase in generic medicine sales compared to last year. The total sales hit Rs. 201.61 crore, showing significant progress from the previous month’s Rs. 110.92 crore. This affordable medicine initiative saved citizens Rs. 806.44 crore, providing much-needed cost relief. ✅ Expansion Highlights: - 420 new JAKs set up in September, now totaling 13,822. - Product range includes 2,047 medicines and 300 surgical items. - Over 14,000 JAKs are active across India, with plans to reach 25,000 by 2026. States like Kerala, Karnataka, and UP led in sales, with Chhattisgarh showing impressive growth. This initiative brings affordable healthcare to millions, with medicines priced 50-90% lower than branded counterparts. #AffordableHealthcare #JanAushadhiKendras #PMBJP #HealthcareForAll #GenericMedicines #HealthcareSavings #PharmaceuticalIndustry

Thyroid Nodule Ablation and Thyroid Artery Embolization is path breaking in the treatment of Thyroid disease. No scar, No major complications, no general anesthesia, Day care procedure.

Exciting Opportunity to Support Healthcare Innovation! We are an India-based pharmaceutical company, established in 2019, currently serving communities across Bihar, Jharkhand, and Uttar Pradesh with 10 trusted brands of general medicines. Our mission is to make high-quality, accessible healthcare a reality, especially in regions where it's most needed. With a strong foundation in general medicine, we’re now ready to expand our reach by introducing dedicated neuro and orthopedic divisions. This next step will allow us to meet growing healthcare demands and address critical needs, but we require funding to bring this vision to life. We’re seeking investors and philanthropists who are passionate about impactful healthcare and innovation. Together, we can create real change in underserved regions, making a difference for countless individuals and families. Join us in building a healthier, more inclusive future. Interested in partnering with us? Let’s connect and discuss how your support can help us shape the future of healthcare!" #partnership #investors #medicalsector #pharma